You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]
|
|---|---|
| Published in |
BMC Dermatology, December 2005
|
| DOI | 10.1186/1471-5945-5-13 |
| Pubmed ID | |
| Authors |
Jean-Paul Ortonne, Neil Shear, Stephen Shumack, Eric Henninger, the CLEAR Multinational Study Group |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 43 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 12 | 28% |
| Student > Ph. D. Student | 7 | 16% |
| Researcher | 5 | 12% |
| Student > Doctoral Student | 2 | 5% |
| Other | 2 | 5% |
| Other | 6 | 14% |
| Unknown | 9 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 20 | 47% |
| Nursing and Health Professions | 3 | 7% |
| Psychology | 3 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Mathematics | 1 | 2% |
| Other | 4 | 9% |
| Unknown | 10 | 23% |